|Table of Contents|

Analysis on incidence,mortality and survival rate of cervical cancer in Chongqing,2021

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 04
Page:
726-731
Research Field:
Publishing date:

Info

Title:
Analysis on incidence,mortality and survival rate of cervical cancer in Chongqing,2021
Author(s):
DING Xianbin1; LYU Xiaoyan1; JIAO Yan1; GAO Yang1; XIONG Juan2; XU Jie1
1.Institute of Non-Communicable Disease Control and Prevention,Chongqing Center for Disease Control and Prevention,Chongqing 400042,China;2.The Second People's Hospital of Yubei District,Chongqing 401147,China.
Keywords:
cervical cancer; incidence; mortality; survival rate
PACS:
R737.33
DOI:
10.3969/j.issn.1672-4992.2024.04.025
Abstract:
Objective:To analyze the incidence,mortality and five years survival rate of cervical cancer in Chongqing,2021 and provide the suggestion for cervical cancer prevention and control.Methods:Cervical cancer cases reported from 39 districts and counties in Chongqing,2021 were analyzed to calculate the incidence,age standardization incidence rate by Chinese (ASIRC) and World standardization population (ASIRW),mortality,age standardization mortality rate by Chinese (ASMRC) and World standardization population (ASMRW) and five years survival rate of cancer.ASIRC and ASIRW were standardized by Chinese and World standardization population proportion in 2000.The difference of cancer incidence and mortality between urban and rural area was compared by Chi-square test.Cases of cervical cancer reported in Chongqing,2016 were followed up by active and passive follow-up.The observed survival rate of cervical cancer was calculated by survival life table.The average survival life time of cervical cancer was calculated by Kaplan-Meier.The difference of survival rate of cancer between urban and rural area was compared by Log Rank of Mantel-Cox.Results:The incidence,ASIRC and ASIRW of cervical cancer was 21.60/100 000,14.64/100 000 and 14.71/100 000 in Chongqing,2021.The incidence of cervical cancer in rural area (23.32/100 000) was higher than that in urban area (17.67/100 000) (χ2=6.96,P＜0.01).The mortality,ASMRC and ASMRW of cervical cancer was 5.00/100 000，2.79/100 000 and 3.02/100 000 in Chongqing,2021.The mortality of cervical cancer in rural area (5.65/100 000)was higher than that in urban area (3.53/100 000)(χ2=5.42,P=0.02).The five years survival rate of cervical cancer was 64.32% in Chongqing,2021.The five years survival rate of cervical cancer in urban area(76.35%) was higher than that in rural area(59.79%)(χ2=46.65,P＜0.01).Conclusion:The incidence and mortality of cervical cancer was high.However,the five years survival rate of cervical cancer was low.It should be attached an importance for cervical cancer prevention and treatment.

References:

［1］SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
［2］ 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析［J］.中华肿瘤杂志,2019,41(1):19-28. ZHENG RS,SUN KX,ZHANG SW,et al.Report of cancer epidemiology in China,2015［J］.Chinese Journal of Oncology,2019,41(1):19-28.
［3］赫捷,魏文强.2019年中国肿瘤登记年报［M］.北京:人民卫生出版社,2021:161-165. HE J,WEI WQ.Cancer registry annual report,2019［M］.Beijing:People Medical Publishing House,2021:161-165.
［4］ 李想,刘灿,周维,等.2005-2015年中国宫颈癌发病与死亡趋势分析［J］.华中科技大学学报（医学版）,2021,50(3):325-330,346. LI X,LIU C,ZHOU W,et al.Changing trend of the incidence and mortality of cervical cancer in China from 2005 to 2015［J］.Acta Medicine University Science & Technology Huazhong,2021,50(3):325-330,346.
［5］丁贤彬,吕晓燕,毛德强,等.2010～2017年重庆市宫颈癌疾病负担变化趋势分析［J］.中国肿瘤,2019,28(9):657-662. DING XB,LYU XY,MAO DQ,et al.Trend analysis of disease burden of cervical cancer from 2010 to 2017 in Chongqing［J］.China Cancer,2019,28(9):657-662.
［6］健康中国行动推进委员会.健康中国行动(2019-2030年):总体要求、重大行动及主要指标［J］.中国循环杂志,2019,34(9):846-858. Promotion Committee of Healthy China Action.Healthy China Action (2019-2030)：General requirements,major actions and major indicators［J］.Chinese Journal of Circulation,2019,34(9):846-858.
［7］ WANNASIN R,LIKITDEE N,KELLY M,et al.Survival after diagnosis of cervical cancer patients at a tertiary referral hospital in northeast thailand［J］.Asian Pac J Cancer Prev,2023,24(5):1759-1767.
［8］ LEE SH,ABDUL RAHIM N,ONG SK,et al.Survival of cervical cancer patients in Brunei Darussalam:2002-2017［J］.Heliyon,2023,9(5):e16080.
［9］ AKBARI A,KHAYAMZADEH M,SALMANIAN R,et al.Epidemiology and survival of cervical cancer in Iran based on national cancer registry data (2008-2014)［J］.Front Oncol,2023,13:1132369.
［10］ 龚巍巍,罗胜兰,胡如英,等.2005-2010年浙江省女性乳腺癌、宫颈癌与卵巢癌生存率分析［J］.中华预防医学杂志,2014,48(5):366-369. GONG W,LUO S,HU R,et al.Analysis of survival rate of breast,cervical,and ovarian cancer patients during 2005-2010 in Zhejiang province,China［J］.Chinese Journal of Preventive Medicine,2014,48(5):366-369.
［11］汪英,王军,徐源佑,等.江苏省启东市1977-2016年宫颈癌生存率趋势分析［J］.中国肿瘤,2022,31(10):782-786. WANG Y,WANG J,XU YY，et al.Survival trend of cervical cancer in Qidong city of Jiangsu Province from 1977 to 2016［J］ China Cancer,2022,31(10):782-786.
［12］SINGH D,VIGNAT J,LORENZONI V,et al.Global estimates of incidence and mortality of cervical cancer in 2020:a baseline analysis of the WHO global cervical cancer elimination initiative［J］.Lancet Glob Health,2023,11(2):e197-e206.
［13］MOMENIMOVAHED Z,MAZIDIMORADI A,MAROOFI P,et al.Global,regional and national burden,incidence,and mortality of cervical cancer［J］.Cancer Rep (Hoboken),2023,6(3):e1756.
［14］SHAHMORADI Z,DAMGACIOGLU H,CLARKE MA,et al.Cervical cancer incidence among US women,2001-2019［J］.JAMA,2022,328(22):2267-2269.
［15］WANG L.Accelerating cervical cancer prevention and control in China to achieve cervical cancer elimination strategy objectives［J］.China CDC Wkly,2022，4(48):1067-1069.
［16］赵宇倩,戴毅,党乐,等.适合中国人群的宫颈癌筛查技术和效果评价的真实世界研究［J］.中华肿瘤杂志,2018,40(10):764-771. ZHAO YQ,DAI Y，DANG L,et al.Real-world research on cervical cancer screening program and effect evaluation for Chinese population［J］.Chinese Journal of Oncology,2018,40(10):764-771.
［17］ 赵琛,宋淑芳.我国宫颈癌流行病学及病因学的研究［J］.医学信息,2021,34(5):6-8. ZHAO C,SONG SF.The epidemiology and etiology of cervical cancer in China ［J］.Journal of Medical Information,2021,34(5):6-8.
［18］重庆市垫江县民政局课题组.重庆市人口老龄化现状、成因及对策分析［J］.重庆行政,2023,1:48-50. Project group of Civil Affairs Bureau of Dianjiang County,Chongqing.Analysis of population aging,causes and measures in Chongqing［J］.Chongqing Administration,2023,1:48-50.
［19］ZHANG M,ZHONG Y,ZHAO Z,et al.Cervical cancer screening rates among Chinese women,China,2015［J］.China CDC Wkly,2020,2(26):481-486.
［20］王瑾瑶,吕海珍,薛志林.中国子宫颈癌死亡率的趋势研究及预测［J］.山西大同大学学报(自然科学版),2019,35(4):49-52. WANG JY,LV HZ，XUE ZL.Trend analysis and prediction of cervical cancer mortality in China［J］.Journal of Shanxi Datong University,2019,35(4):49-52.
［21］WEN X,WEN D,YANG Y,et al.Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess［J］.Medicine (Baltimore),2019,98(1):e13907.
［22］SUN K,ZHENG R,LEI L,et al.Trends in incidence rates,mortality rates,and Age-Period-Cohort effects of cervical cancer-China,2003-2017［J］.China CDC Wkly,2022,4(48):1070-1076.
［23］庞怡,吴春晓,顾凯,等.2016年上海市子宫颈癌发病和死亡情况与2002-2016年的变化趋势分析［J］.中国癌症杂志,2022,32(6):519-526. PANG Y,WU CX,GU K,et al.Analysis of current status of cervical cancer incidence and mortality in Shanghai,2016 and trends of 2002-2016［J］.China Oncology,2022,32(6):519-526.
［24］王瑾瑶,张年萍,白志强,等.1993-2017年中国宫颈癌发病率和死亡率长期趋势的年龄-时期-队列模型分析［J］.中国全科医学,2022,25(13):1564-1568. WANG JY，ZHANG NP，BAI ZQ，et al.Age-period-cohort analysis of secular trends of cervical cancer incidence and mortality in China，1993-2017［J］.Chinese General Practice,2022,25(13):1564-1568.
［25］DROKOW EK,FANGNINOU FF,EFFAH CY,et al.Cervical cancer survival times in Africa［J］.Front Public Health,2022,10:981383.
［26］ZOU M,LIU H,LIU H,et al.Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China［J］.Front Immunol,2023,14:1119566.
［27］ZHANG X,CHEN W,ZHU X,et al.Multiple center research on relationship between screening quality and detection of cervical cancer-six provinces,China,June-December 2021［J］.China CDC Wkly,2023,5(14):301-305.
［28］CHARGARI C,ARBYN M,LEARY A,et al.Increasing global accessibility to high-level treatments for cervical cancers［J］.Gynecol Oncol,2022,164(1):231-241.
［29］ BHADELIA A.Evidence for the path to cervical cancer elimination［J］.Lancet Glob Health,2020,8(2):e155-e156.

Memo

Memo:
国家重点研发计划（编号：2018YFC1311702）
Last Update: 1900-01-01